Population Prevalence, Penetrance, and Mortality for Genetically Confirmed MODY
This large-scale genotype-first study provides novel insights into MODY in the population. These findings have broad implications for genetic counselling, personalised treatment strategies, and healthcare resource allocation.
Authors
- Kevin Colclough (ORCID: https://orcid.org/0000-0003-0566-4853)
- Stuart J Cannon (ORCID: https://orcid.org/0000-0002-5108-7615)
- Luke N Sharp (ORCID: https://orcid.org/0009-0001-3657-5493)
- Thomas W. Laver (ORCID: https://orcid.org/0000-0001-6399-0089)
- Andrew Tym Hattersley (ORCID: https://orcid.org/0000-0001-5620-473X)
- James H. Leech (ORCID: https://orcid.org/0000-0001-6990-5826)
- Kashyap Patel (ORCID: https://orcid.org/0000-0002-9240-8104)
- Michael N. Weedon (ORCID: https://orcid.org/0000-0002-6174-6135)
Institutions
- University of Exeter (GB)
- Royal Devon & Exeter NHS Foundation Trust (GB)
Publication Details
- Journal
- The Journal of Clinical Endocrinology & Metabolism
- Published
- 2025-10-31
- DOI
- https://doi.org/10.1210/clinem/dgaf599
- Citations
- 1
- Primary Topic
- Genetic Associations and Epidemiology
- Type
- article
- Field-Weighted Citation Impact
- 1.82
Funders
- Wellcome Trust
- National Institute for Health and Care Research
- British Heart Foundation
- Diabetes UK
- Medical Research Council